AstraZeneca PLC (AZN) price target and intrinsic value estimate
AZN's fair price estimate is $58.8.
This valuation is based on a fair P/E of 14.7 and EPS estimates of $4.01, and calculated using the pevaluation method.
AZN is currently trading at $64.49 (10% overvalued).
0Is AZN overvalued or undervalued?
AZN is overvalued by 10% using the pevaluation method.
0Current price | $64.5 |
Fair price | $58.8 |
Define your own market model and access personalized fair price estimates today!
Health Care
Pharmaceuticals
Market cap:$ 199.79(B)
Enterprise value:$ 227.04(B)
Div. yield:2.30%
P/E:30.98
P/FCF:21.20
P/B:5.06
PEvaluation
Economic moat: None/narrow
Fair P/E
Margin of safety
EPS estimates
Analyst recommendations
S. Sell:
0Sell:
2Hold:
3Buy:
10S. Buy:
4
0Sell:
2Hold:
3Buy:
10S. Buy:
4
Historical financials
Showing limited histrical data. Access 10+ years of financials now! Upgrade
Income
RevenueNet IncomeCOGSGross ProfitTotal OpEx.R&DSG&AOperating IncomeInterest ExpenseInterest IncomePre-tax incomeIncome tax
Cash flow
FCFCFONet IncomeD&AStock-based Comp.CFFStock IssuedStock RepurchasedDebt IssuedDebt RepaidDividend PaidCFIAcquisitionsDivestituresCapital Expenditures
Balance sheet
Total AssetsTotal LiabilitiesCurrent assetsCash and EquivalentsShort-term investmentsInventoriesReceivablesNon-current assetsNet PP&EGoodwillCurrent liabilitiesAccounts payableNon-current liabilitiesLong-Term DebtTotal Equity
Shares outstanding
Shares (Basic)Shares (Diluted)
Per share data
EPS (Basic)EPS (Diluted)FCF/ShareDividend/ShareBook value/Share
Ratios
P/EP/FCFP/BP/SEV/EarningsEV/FCFDebt/EquityPayout ratio
Margins
Net Income MarginOperating MarginGross MarginEBITDA MarginFCF Margin
Returns
ROICROAROCEROE
Market Cap.
Market Cap.